webinar register page

Webinar banner
Will the coronavirus pandemic finally lead to an upswing in R&D to tackle neglected areas like antibiotic resistance, zoonotic transmission of pathogens and a more globally-coordinated approach.
Category: Pharma
> Infectious diseases and reproductive health

> MaryAnne Rizk, PhD
Senior Vice President, R&D Digital Strategy, IQVIA

> Mark Sullivan
Founder and Managing Director, Medicines Development for Global Health
> Amanda Paschke, MD, MSCE
Executive Director Global Clinical Development, Merck & Co., Inc.
> Dennis E. Hruby, Ph.D.
Chief Scientific Officer, SIGA Technologies, Inc.
> Daniel Everitt, MD
Vice President and Chief Medical Officer, TB Alliance

Oct 28, 2020 03:00 PM in Eastern Time (US and Canada)

Webinar logo
* Required information

By registering, I agree to the Privacy Statement and Terms of Service.